Atherosclerosis
Rat study suggests low-dose estrogen protects against clogged arteries
Published in Women's Health Weekly, January 6th, 2005
"The current regimens of hormone replacement therapy for postmenopausal women, estrogen combined with progestogen, have failed to show beneficial effects for the prevention of atherosclerotic disease. Although the relatively higher dose of estrogen contained in those regimens exerted adverse effects, there are few data examining a lower dose of estrogen in an atherosclerosis model," wrote T. Watanabe, University of Tokyo, and colleagues.
Thus, they "investigated experimentally whether lower doses of estrogen could inhibit neointimal formation...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
More Articles from Women's Health Weekly
- At-Risk Populations
Teenage girls targeted for sweet-flavored alcoholic beverages - Breast Cancer
Small variations in genes can determine risk of developing disease - Breast Cancer
Study examines impact of 2-year screening interval - Hypertension
eNOS gene may influence predisposition to high blood pressure in females - Obstetrics
Study: Absolute risk of complications from VBAC is very small - Accreditations
Humana's Louisiana operations awarded 3-year Excellent Accreditation by NCQA - More from this issue of Women's Health Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
